Hong-yu Zhang

Zhuhai, 519000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Mitogen-activated protein kinase 10 suppresses non-small cell lung cancer metastasis through phosphorylation-dependent ubiquitination of keratin 16.

Mitogen-activated protein kinase 10 suppresses non-small cell lung cancer metastasis through phosphorylation-dependent ubiquitination of keratin 16.

Journal: International journal of biological macromolecules

Published: September 11, 2025

Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial.

Electro-acupuncture for quality of life during adjuvant chemotherapy in gastric cancer: a randomized trial.

Journal: Journal of the National Cancer Institute

Published: May 22, 2025

CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway.

CYP4F11 promotes lung cancer progression through the miR-195/ME2 pathway.

Journal: Frontiers of medicine

Published: April 01, 2025

RAB3A-mediated BAG6 translocation promotes non-small cell lung cancer tumorigenesis and progression.

RAB3A-mediated BAG6 translocation promotes non-small cell lung cancer tumorigenesis and progression.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: February 09, 2025

The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.

The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis.

Journal: Cancer immunology, immunotherapy : CII

Published: February 16, 2024

Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.

Neoadjuvant chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in elderly patients with stage III-IVa nasopharyngeal carcinoma: A real-world study based on medical comorbidities.

Journal: Head & neck

Published: May 29, 2023

Response to the letter by Dr Sari regarding the article "The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy".

Response to the letter by Dr Sari regarding the article "The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy".

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: January 09, 2023

The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.

The feasibility of reduced-dose radiotherapy in childhood nasopharyngeal carcinoma with favorable response to neoadjuvant chemotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 13, 2022

FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer.

FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: March 16, 2022

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.

Safety and efficacy of S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy: multi-institutional retrospective analysis.

Journal: Drug design, development and therapy

Published: August 26, 2014

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.

Journal: Cancer chemotherapy and pharmacology

Published: March 18, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026